Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Myofibroma 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

aflibercept 2Radiotherapy 2trastuzumab deruxtecan 1entinostat 1Topotecan 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Ritonavir 1Radiation 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Octreotide 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Indinavir 1Immunotherapy 1Hysterectomy 1Gene Rearrangement 1Gene Expression Profiling 1Fondaparinux 1Fluorodeoxyglucose F18 1Fentanyl 1FAPI-46 1Drug Therapy 1Docetaxel 1CA-125 Antigen 1Buthionine Sulfoximine 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vaginal Neoplasms × CA-125 Antigen × Sarcoma × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡